spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  5AM Ventures 

 HSMN NewsFeed - 28 Jul 2025
MapLight Therapeutics Announces $372.5 Million Series D Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 17 Mar 2025
Latigo Biotherapeutics Closes $150 Million in Series B Financing to Advance Non-Opioid Pain Therapeutics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Jul 2024
Latigo Biotherapeutics Appoints Nima Farzan as Chief Executive Officer, Positioning Company for Rapid Growth
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2024
Latigo Biotherapeutics Debuts with $135 Million Series A Financing to Develop Non-Opioid Pain Medicines
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 2 Feb 2024
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Sep 2021
Disc Medicine Announces $90 Million Series B Financing to Advance Portfolio of Clinical-Stage Therapies for Hematologic Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 May 2021
Soteria Biotherapeutics Launches with $42 Million Series A Financing Led by Roche Venture Fund and 5AM Ventures
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 3 Jun 2020
Novo Ventures Leads US$55M Series B Investment in NodThera
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Jul 2019
IDEAYA Biosciences Strengthens Management with Internal Appointments of Paul Stone, J.D., as Chief Financial Officer, Andres Ruiz Briseno, C.P.A., as Vice President, Finance, and Mick O'Quigley, M.B.A, as Vice President, Development Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Apr 2019
Aprea Therapeutics Receives FDA Fast Track Designation and Orphan Drug Designation for APR-246 for the Treatment of Myelodysplastic Syndromes (MDS)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Mar 2019
Aprea Therapeutics Appoints Dr. Eyal C. Attar as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Feb 2019
Aprea Therapeutics Adds New Investor to Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 12 Dec 2018
Magnetic Insight Raises $18M to Support Commercial Growth of Magnetic Particle Imaging in Cell Therapy, Vascular and Oncology Applications
Devices Radiology Venture Capital Personnel
 HSMN NewsFeed - 5 Jun 2018
IDEAYA Biosciences Appoints Paul Stone, J.D., as Senior Vice President and General Counsel, Head of Operations and Mark Lackner, Ph.D. as Vice President, Head of Biomarkers and Synthetic Lethal Biology
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Apr 2018
Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 4 Jan 2018
Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 27 Nov 2017
Laura Shawver, Ph.D., Appointed CEO of Synthorx
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2017
Relay Therapeutics Appoints Pharmaceutical Leader Sanjiv K. Patel, M.D. to President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2016
Ceterix Announces Appointment of Edward Graubart as Vice President, Sales
Devices Orthopaedic Personnel
 HSMN NewsFeed - 9 Mar 2016
Karolinska Development's Portfolio Company Aprea Raises SEK 437 Million
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 21 Oct 2015
Arvinas Secures $41.6M Series B Financing - Appoints New Board Members
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 29 Sep 2015
Precision NanoSystems Raises $13.4M in Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Mar 2015
Ceterix Announces Publication of Studies Demonstrating Advantages of Meniscus Repair With Minimally Invasive Orthopaedic Suturing Device
Devices Orthopaedic
 HSMN NewsFeed - 2 Dec 2014
Audentes Therapeutics Raises $42.5 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jun 2014
Cidara Therapeutics Completes $32 Million Series A Financing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 May 2014
Ceterix Orthopaedics Completes $18 Million Financing
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 16 Apr 2014
Epirus and Zalicus Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions Venture Capital
 HSMN NewsFeed - 28 Jan 2014
Igenica Raises $14 Million in Additional Series C Funding to Advance Product Pipeline and Technology Platform
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 18 Jul 2013
Audentes Therapeutics Raises $30 Million in Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Jul 2013
Ceterix Announces U.S. Launch of Novel Device for Minimally Invasive Orthopaedic Procedures
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 9 Apr 2013
Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 25 Mar 2013
Novira Therapeutics Completes $25 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 22 Jan 2013
Ceterix Orthopaedics Completes $19.5 Million Series B Financing
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 12 Dec 2012
The Medicines Company Agrees to Acquire Incline Therapeutics, Inc.
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 4 Dec 2012
Flexion Therapeutics Secures $20 Million in Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 13 Nov 2012
Pearl Therapeutics Raises $65 Million Series D to Start PT003 Phase 3
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Nov 2012
Takeda to Acquire Envoy Therapeutics, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Aug 2012
Atterocor Launches Innovative Company Focused on Accelerated Development of Treatment for Adrenal Cancer; Secures $16 Million Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 10 May 2012
Incline Therapeutics Announces Appointment of John Tucker as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Oct 2011
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 15 Aug 2011
Pulmatrix Secures a $14 million Financing to Advance Clinical Programs in COPD and Cystic Fibrosis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Feb 2011
Pearl Therapeutics Appoints Charles (Chuck) Bramlage President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 6 Jan 2011
Viveve Obtains CE Mark for Gynecologic Treatment of Vaginal Laxity
Devices Regulatory
 HSMN NewsFeed - 19 Oct 2010
Pearl Therapeutics Raises $69 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Oct 2010
Synosia Therapeutics Raises $30M in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Sep 2010
Relypsa Raises $70 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Jun 2010
Relypsa Appoints Claire J. Lockey Vice President, Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Oct 2009
Flexion Therapeutics Raises $33 Million in Series A Financing
Biopharmacetuicals Venture Capital
 HSMN NewsFeed - 2 Mar 2009
Pearl Therapeutics Appoints Perry Karsen as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2009
Anaphore, Inc. Announces $25 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Dec 2008
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Sep 2008
KaloBios Raises $20 Million in Series D Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Jul 2008
Pearl Therapeutics Closes $18 Million Financing Round Led By Committed Investors
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Apr 2008
Anaphore, Inc Receives $8M Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Feb 2008
5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
Venture Capital Personnel
 HSMN NewsFeed - 20 Dec 2007
Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2007
Synosia Therapeutics Announces Appointment of Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Nov 2007
Synosia Therapeutics Announces Appointment of Vice President of Clinical Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2007
Relypsa Formed With $33 Million Series A Funding to Discover and Develop Polymeric Drugs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 May 2007
New Agreement Boosts Pipeline for Synosia Therapeutics
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 May 2007
Synosia Therapeutics Announces Appointment of Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 May 2007
Marcadia Biotech Completes $15 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 May 2007
Ilypsa Announces Promotion of Paul A. Stone to Senior Vice President, General Counsel and Chief Patent Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2007
Roche and Synosis Therapeutics Announce Partnership to Explore Potential of Five Compounds Targeting the Central Nervous System
Biopharmaceuticals
 HSMN NewsFeed - 12 Dec 2006
Ilypsa Announces Promotion of Gerrit Klaerner, Ph.D. to Senior Vice President and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Oct 2006
Ilypsa Announces Appointment of William D. Waddill as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Oct 2006
Achaogen Closes Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 May 2006
Antipodean Pharmaceuticals Initiates Phase 2 Trial in Parkinson's Disease
Biopharmaceuticals Neurology
Return to NewsFeed  

 Additional items found! 7

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 7 additional stories matching:
5AM Ventures
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!